Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glulisine versus insulin aspart and insulin lispro in CSII for type 1 diabetes
2007-003579-38Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin glulisine in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Sanofi. Primary endpoint: Unexplained hyperglycemia and/or infusion set occlusion. Started Oct 2007; status: completed.
02
Drugs
insulin glulisine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2007-003579-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003579-38.